Arena Pharmaceuticals Inc (NASDAQ:ARNA)

Delayed Data
As of Apr 23
 -0.55 / -1.39%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 62.00, with a high estimate of 79.00 and a low estimate of 48.00. The median estimate represents a +58.41% increase from the last price of 39.14.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Arena Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -79.55%
Growthannually -3.69%


Growthquarterly -64.20%
Growthannually -41.44%
Key to the earnings and sales forecast charts.